SPONSOR
Jiangsu Hansoh Pharmaceutical Co., Ltd.
Total Trials
4
Recruiting
4
Phases
Phase 1, Phase 1, Phase 2, Phase 2
Conditions studied: Recurrent Ovarian CancerHER2-negativeAdvanced Breast CancerTNBCAdvanced Prostate CancerAdvanced Gastric CancerAdvanced Clear Cell Renal Cell CarcinomaNon-Small Cell Lung CancerNonsmall Cell Lung Cancer
Jiangsu Hansoh Pharmaceutical Co., Ltd. is a clinical research sponsor with 4 registered studies on ClinicalTrials.gov, of which 4 are actively recruiting participants. Research covers conditions including Recurrent Ovarian Cancer, HER2-negative, Advanced Breast Cancer, TNBC.
The trial portfolio spans Phase 1, Phase 1, Phase 2, Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Jiangsu Hansoh Pharmaceutical Co., Ltd.
How many clinical trials has Jiangsu Hansoh Pharmaceutical Co., Ltd. sponsored?
ClinicalMetric currently tracks 4 clinical trials sponsored by Jiangsu Hansoh Pharmaceutical Co., Ltd., of which 4 are actively recruiting participants. These trials cover conditions including Recurrent Ovarian Cancer, HER2-negative, Advanced Breast Cancer. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Jiangsu Hansoh Pharmaceutical Co., Ltd. research focus on?
Jiangsu Hansoh Pharmaceutical Co., Ltd. clinical trials span Recurrent Ovarian Cancer, HER2-negative, Advanced Breast Cancer, TNBC, Advanced Prostate Cancer, and additional conditions. The research pipeline includes Phase 1, Phase 1, Phase 2, Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Jiangsu Hansoh Pharmaceutical Co., Ltd. clinical trial?
To participate in a Jiangsu Hansoh Pharmaceutical Co., Ltd. trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Jiangsu Hansoh Pharmaceutical Co., Ltd. trials with current recruitment status updated daily.
Clinical Trials by Jiangsu Hansoh Pharmaceutical Co., Ltd.
NCT06769425 Phase 1
Recruiting
HS-10502 Combination Treatment in Patients With Advanced Solid Tumors
Recurrent Ovarian Cancer
NCT07097935 Phase 1, Phase 2
Recruiting
Study of HS-10516 Combination Therapy in Patients With Advanced Renal Cell Carcinoma
Advanced Clear Cell Renal Cell Carcinoma
NCT07130916 Phase 1
Recruiting
A Study of Aumolertinib in European Participants With Non-Small Cell Lung Cancer
Non-Small Cell Lung Cancer
NCT06147570 Phase 2
Recruiting
A Study of HS-10365 in Patients With Advanced or Metastatic RET Fusion-Positive Non-Small Cell Lung Cancer
Nonsmall Cell Lung Cancer
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: November 2026 · Data Methodology